Altered gray matter structural covariance networks in drug-naïve and treated early HIV-infected individuals

Altered gray matter structural covariance networks in drug-naïve and treated early HIV-infected individuals

BackgroundWhile regional brain structure and function alterations in HIV-infected individuals have been reported, knowledge about the topological organization in gray matter networks is limited. This research aims to investigate the effects of early HIV infection and combination antiretroviral thera...

Full description

Bibliographic Details
Main Authors:	Ruili Li, Yuxun Gao, Wei Wang, Zengxin Jiao, Bo Rao, Guangxue Liu, Hongjun Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Neurology
Subjects:	HIV cognitive function combination antiretroviral therapy 3D-T1WI structural covariance network
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2022.869871/full

Similar Items

Selective disrupted gray matter volume covariance of amygdala subregions in schizophrenia
by: Zhongyu Chang, et al.
Published: (2024-04-01)

Gray matter covariations in autism: out-of-sample replication using the ENIGMA autism cohort
by: Ting Mei, et al.
Published: (2024-01-01)

Gray Matter Covariance Networks as Classifiers and Predictors of Cognitive Function in Alzheimer’s Disease
by: Fabian Wagner, et al.
Published: (2020-05-01)

Frequency-dependent functional alterations in people living with HIV with early stage of HIV-associated neurocognitive disorder
by: Wei Wang, et al.
Published: (2023-01-01)

Parahippocampus hypertrophy drives gray matter morphological alterations in migraine patients without aura
by: Tao Yin, et al.
Published: (2023-05-01)

Combined training improves the diagnostic measures of sarcopenia and decreases the inflammation in HIV‐infected individuals
by: Morteza Ghayomzadeh, et al.
Published: (2022-04-01)

The Adherence to Fixed-Dose Combination Antiretroviral Therapy and Viral Load in HIV Patients
by: Salma Auliannissa, et al.
Published: (2020-01-01)

Relationship between Modern ART Regimens and Immunosenescence Markers in Patients with Chronic HIV Infection
by: Rusina Grozdeva, et al.
Published: (2024-07-01)

HIV-1 drug resistance among naïve patients in Armenia in 2017–2021
by: Olga A. Osadchaya, et al.
Published: (2024-05-01)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Sharlene Ho, et al.
Published: (2020-05-01)

Regression of HIV-associated pulmonary arterial hypertension and long-term survival during antiretroviral therapy
by: R Jaccard
Published: (2001-11-01)

Association of myocardial iron deficiency based on T2* CMR with the risk of mild left ventricular dysfunction in HIV-1-infected patients
by: Chengxi Yan, et al.
Published: (2023-04-01)

Age-Related Regional Network Covariance of Magnetic Resonance Imaging Gray Matter in the Rat
by: Gene E. Alexander, et al.
Published: (2020-08-01)

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV
by: Amanda Binkley, et al.
Published: (2024-10-01)

Transmitted drug resistance and transmission clusters among ART-naïve HIV-1-infected individuals from 2019 to 2021 in Nanjing, China
by: Yuanyuan Xu, et al.
Published: (2023-08-01)

In Search of Covariates of HIV-1 Subtype B Spread in the United States—A Cautionary Tale of Large-Scale Bayesian Phylogeography
by: Samuel L. Hong, et al.
Published: (2020-02-01)

Closing the gaps: Steps towards elimination of mother-to-child transmission of HIV
by: Mary Ibeto, et al.
Published: (2014-09-01)

Ten Years HIV Free: An Interview with “The Berlin Patient,” Timothy Ray Brown
by: Michael M. Lederman, et al.
Published: (2017-11-01)

Depression as a Risk Factor for Incident Ischemic Stroke Among HIV‐Positive Veterans in the Veterans Aging Cohort Study
by: Jason J. Sico, et al.
Published: (2021-07-01)

Dynamic Changes in Breast Milk Microbiome in the Early Postpartum Period of Kenyan Women Living with HIV Are Influenced by Antibiotics but Not Antiretrovirals
by: Rabia Maqsood, et al.
Published: (2022-04-01)

Doravirine-associated resistance mutations in antiretroviral therapy naïve and experienced adults with HIV-1 subtype C infection in Botswana
by: Ontlametse T. Bareng, et al.
Published: (2022-12-01)

Comparison of Immunological and Virological Recovery with Rapid, Early, and Late Start of Antiretroviral Treatment in Naive Plwh: Real-World Data
by: Sarıgül Yıldırım F, et al.
Published: (2023-05-01)

Prevalence of hypoalbuminemia in outpatients with HIV/AIDS
by: José Adalberto Leal, et al.

HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients
by: Elmi Abar Aden, et al.
Published: (2012-10-01)

A Pregnant Patient with Advanced HIV/AIDS
by: Özlem Altuntafl Ayd›n, et al.
Published: (2011-03-01)

Brief communication: efficacy and safety of the dolutegravir/lamivudine dual therapy in antiretroviral treatment-experienced Chinese people living with HIV
by: Zhenyan Wang, et al.
Published: (2024-11-01)

Differences in Expression of Selected Interleukins in HIV-Infected Subjects Undergoing Antiretroviral Therapy
by: Beata Szymańska, et al.
Published: (2022-05-01)

A Case of Neuro-AIDS Presenting with Rapidly Progressive Dementia and Parkinsonism with Rapid Response to Treatment
by: Yasemin Akıncı, et al.
Published: (2017-06-01)

Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates Efeito das drogas anti-retrovirais sobre os valores dos linfócitos TCD4, RNA do HIV-1 e parâmetros antropométricos de neonatos de gestantes portadoras do HIV-1
by: Patrícia El Beitune, et al.
Published: (2005-06-01)

HIV and Osteoporosis: Three Case Reports and Review of the Literature
by: Kerem Gün, et al.
Published: (2012-04-01)

Gray matter structural covariance networks patterns associated with autopsy-confirmed LATE-NC compared to Alzheimer's disease pathology
by: Kaicheng Li, et al.
Published: (2023-12-01)

Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV
by: Samantha Climaco-Arvizu, et al.
Published: (2022-05-01)

The Evaluation of Carotid Atherosclerosis in Patients with the HIV-1 Infection: The Role of the Antiretroviral Therapy
by: Suparna P.N, et al.
Published: (2013-02-01)

Development of a risk stratification model for pharmaceutical care in HIV patients
by: Ramón Morillo-Verdugo, et al.
Published: (2017-05-01)

Longitudinal white matter alterations in SIVmac239-infected rhesus monkeys with and without regular cART treatment
by: Jiaojiao Liu, et al.
Published: (2023-01-01)

A longitudinal study of the brain structure network changes in HIV patients with ANI: combined VBM with SCN
by: Fan Xu, et al.
Published: (2024-04-01)

HIV-infection is spreading
by: V V Pokrovsky
Published: (2004-04-01)

Immune reconstitution efficacy after combination antiretroviral therapy in male HIV-1 infected patients with homosexual and heterosexual transmission
by: You Ge, et al.
Published: (2023-12-01)

Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania
by: Evangelista Malindisa, et al.
Published: (2023-04-01)

Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment
by: Hines DM, et al.
Published: (2019-11-01)